Patent · US Active

Combination of brimonidine and timolol for topical ophthalmic use

US7642258B2 · kind B2 · utility

14Cited by

18References

9Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Chin-Ming Chang · Tustin, US
Gary J. Beck · Fullerton, US
Cynthia C. Pratt · Mission Viejo, US
Amy L. Batoosingh · Mission Viejo, US

Key dates

Filing date	Aug 24, 2007
Grant date	Jan 5, 2010
Priority date	—
Expiry date	Apr 7, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.